Former Chief Medical Officer · Protara Therapeutics, Inc. (TARA)

Julio Casoy

A named executive officer of Protara Therapeutics in every fiscal year CompBrief holds from FY2019 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$2,179,698

Salary $234,054Stock awards $1,365,000

FY2019: $622,491

3rd of 4 named executive officers at Protara Therapeutics by FY2020 total.

4 named officers on file for Protara Therapeutics, FY2020

Julio Casoy’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Protara Therapeutics’s whole pay program stands against its peers

  • Protara Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TARA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2021 (DEF 14A).

Free

Get Julio Casoy’s full pay file as a PDF — free

More than this page: up to 10 years of Julio’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Julio Casoy compensation by year

Protara Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Protara Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020
Salary$348,504$234,054
Bonus$0$0
Stock awards$0$1,365,000
Option awards$255,920$0
Non-equity incentive$0$115,500
Pension and deferred compensation$0$0
All other$18,067$464,144
Total$622,491$2,179,698

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Protara Therapeutics, Inc. DEF 14A filed April 27, 2021, accession 0001213900-21-023066, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Protara Therapeutics, Inc. filed document, accession 0001213900-21-023066. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2021.

$622K
$2.2M
FY19
FY20
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
Option30,201—$9.18

Per the Outstanding Equity Awards at Fiscal Year-End table in Protara Therapeutics, Inc.'s FY2019 proxy; value at the fiscal year-end close, as the company printed it.

Protara Therapeutics’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Jesse SheffermanPresident, Chief Executive Officer and Director$7,755,378
Blaine DavisChief Financial Officer$3,383,602
Julio Casoy · this pageFormer Chief Medical Officer$2,179,698
Jacqueline ZummoChief Scientific Operations Officer$1,991,181

The full Protara Therapeutics compensation record

free company brief

This page is one person within Protara Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Protara Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Julio Casoy's compensation dossier · One-time report. No refunds.